Safety issue considered by the Marketing Authorization Holder in relation to an authorized medicinal product under its responsibility to require urgent action of the competent authority because of the potential major impact on the benefit-risk balance of the product and/or on patient or public health, that could warrant prompt regulatory action and communication to patients and healthcare professionals.